Cargando…
Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells
Osteosarcoma is the most common primary malignant bone tumor. Although cisplatin is the primary chemotherapy used in osteosarcoma treatment, the cisplatin resistance remains a big challenge for improving overall survival. The store-operated calcium (Ca(2+)) entry (SOCE) and its major mediator Stim1...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Japan
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486860/ https://www.ncbi.nlm.nih.gov/pubmed/28326487 http://dx.doi.org/10.1007/s13577-017-0167-9 |